165 related articles for article (PubMed ID: 8765411)
1. Antitumor and antimetastatic effects of interleukin 12.
Fujiwara H; Hamaoka T
Cancer Chemother Pharmacol; 1996; 38 Suppl():S22-6. PubMed ID: 8765411
[TBL] [Abstract][Full Text] [Related]
2. Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells.
Zou JP; Yamamoto N; Fujii T; Takenaka H; Kobayashi M; Herrmann SH; Wolf SF; Fujiwara H; Hamaoka T
Int Immunol; 1995 Jul; 7(7):1135-45. PubMed ID: 8527411
[TBL] [Abstract][Full Text] [Related]
3. Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes.
Mu J; Zou JP; Yamamoto N; Tsutsui T; Tai XG; Kobayashi M; Herrmann S; Fujiwara H; Hamaoka T
Cancer Res; 1995 Oct; 55(19):4404-8. PubMed ID: 7671253
[TBL] [Abstract][Full Text] [Related]
4. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression.
Ogawa M; Yu WG; Umehara K; Iwasaki M; Wijesuriya R; Tsujimura T; Kubo T; Fujiwara H; Hamaoka T
Cancer Res; 1998 Jun; 58(11):2426-32. PubMed ID: 9622084
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms underlying IFN-gamma-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12.
Yu WG; Yamamoto N; Takenaka H; Mu J; Tai XG; Zou JP; Ogawa M; Tsutsui T; Wijesuriya R; Yoshida R; Herrmann S; Fujiwara H; Hamaoka T
Int Immunol; 1996 Jun; 8(6):855-65. PubMed ID: 8671675
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 12 gene transfer into skin distant from the tumor site elicits antimetastatic effects equivalent to local gene transfer.
Oshikawa K; Rakhmilevich AL; Shi F; Sondel PM; Yang N; Mahvi DM
Hum Gene Ther; 2001 Jan; 12(2):149-60. PubMed ID: 11177552
[TBL] [Abstract][Full Text] [Related]
7. The anti-tumor effects of IL-12 involve enhanced IFN-gamma production by anti-tumor T cells, their accumulation to tumor sites and in situ IFN-gamma production.
Fujiwara H; Hamaoka T
Leukemia; 1997 Apr; 11 Suppl 3():570-1. PubMed ID: 9209457
[TBL] [Abstract][Full Text] [Related]
8. IL-12-induced tumor regression correlates with in situ activity of IFN-gamma produced by tumor-infiltrating cells and its secondary induction of anti-tumor pathways.
Yu WG; Ogawa M; Mu J; Umehara K; Tsujimura T; Fujiwara H; Hamaoka T
J Leukoc Biol; 1997 Oct; 62(4):450-7. PubMed ID: 9335314
[TBL] [Abstract][Full Text] [Related]
9. The development of peritumoral stroma required for IL-12 induced tumor regression depends on the T cell/IFN-gamma-involving host-tumor interaction.
Uekusa Y; Ogawa M; Gao P; Iwasaki M; Ono S; Tsujimura T; Nakazawa M; Sakuda M; Clancy B; Fujiwara H; Hamaoka T
Int J Oncol; 2000 Apr; 16(4):805-14. PubMed ID: 10717251
[TBL] [Abstract][Full Text] [Related]
10. Enhanced induction of very late antigen 4/lymphocyte function-associated antigen 1-dependent T-cell migration to tumor sites following administration of interleukin 12.
Ogawa M; Tsutsui T; Zou JP; Mu J; Wijesuriya R; Yu WG; Herrmann S; Kubo T; Fujiwara H; Hamaoka T
Cancer Res; 1997 Jun; 57(11):2216-22. PubMed ID: 9187124
[TBL] [Abstract][Full Text] [Related]
11. Differential IL-12 responsiveness of T cells but not of NK cells from tumor-bearing mice in IL-12-responsive versus -unresponsive tumor models.
Iwasaki M; Yu WG; Uekusa Y; Nakajima C; Yang YF; Gao P; Wijesuriya R; Fujiwara H; Hamaoka T
Int Immunol; 2000 May; 12(5):701-9. PubMed ID: 10784616
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of interleukin 12 in preclinical models.
Brunda MJ; Luistro L; Rumennik L; Wright RB; Dvorozniak M; Aglione A; Wigginton JM; Wiltrout RH; Hendrzak JA; Palleroni AV
Cancer Chemother Pharmacol; 1996; 38 Suppl():S16-21. PubMed ID: 8765410
[TBL] [Abstract][Full Text] [Related]
13. Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.
Nastala CL; Edington HD; McKinney TG; Tahara H; Nalesnik MA; Brunda MJ; Gately MK; Wolf SF; Schreiber RD; Storkus WJ
J Immunol; 1994 Aug; 153(4):1697-706. PubMed ID: 7913943
[TBL] [Abstract][Full Text] [Related]
14. Enhanced induction of antitumor T-cell responses by cytotoxic T lymphocyte-associated molecule-4 blockade: the effect is manifested only at the restricted tumor-bearing stages.
Yang YF; Zou JP; Mu J; Wijesuriya R; Ono S; Walunas T; Bluestone J; Fujiwara H; Hamaoka T
Cancer Res; 1997 Sep; 57(18):4036-41. PubMed ID: 9307290
[TBL] [Abstract][Full Text] [Related]
15. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
16. Administration of IL-12 induces a CD3+ CD4- CD8- B220+ lymphoid population capable of eliciting cytolysis against Fas-positive tumor cells.
Tsutsui T; Mu J; Ogawa M; Yu WG; Suda T; Nagaga S; Saji F; Murata Y; Fujiwara H; Hamaoka T
J Immunol; 1997 Sep; 159(6):2599-605. PubMed ID: 9300678
[TBL] [Abstract][Full Text] [Related]
17. Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity.
Guo J; Wang B; Zhang M; Chen T; Yu Y; Regulier E; Homann HE; Qin Z; Ju DW; Cao X
Gene Ther; 2002 Jun; 9(12):793-803. PubMed ID: 12040461
[TBL] [Abstract][Full Text] [Related]
18. Generation of a tumor-specific systemic response after intratumoral injection of IL-12 and IL-18-loaded polylactic acid microspheres.
Sabel MS; Arora A; Su G; Griffith KA; Mathiowitz E; Reineke JJ; Chang AE
J Immunother; 2007; 30(8):808-16. PubMed ID: 18049332
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
Hafner M; Falk W; Echtenacher B; Männel DN
Eur Cytokine Netw; 1999 Dec; 10(4):541-8. PubMed ID: 10586121
[TBL] [Abstract][Full Text] [Related]
20. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
Osaki T; Péron JM; Cai Q; Okamura H; Robbins PD; Kurimoto M; Lotze MT; Tahara H
J Immunol; 1998 Feb; 160(4):1742-9. PubMed ID: 9469432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]